The discoidin domain receptors, DDR1 and DDR2, are receptor tyrosine kinases that bind to and are activated by collagens. Similar to collagen-binding β1 integrins, the DDRs bind to specific motifs within the collagen triple helix. However, these two types of collagen receptors recognize distinct collagen sequences. While GVMGFO (O is hydroxyproline) functions as a major DDR binding motif in fibrillar collagens, integrins bind to sequences containing Gxx’GEx”. The DDRs are thought to regulate cell adhesion, but their roles have hitherto only been studied indirectly. In this study we used synthetic triple-helical collagen-derived peptides that incorporate either the DDR-selective GVMGFO motif or integrin-selective motifs, such as GxOGER and GLOGEN, in order to selectively target either type of receptor and resolve their contributions to cell adhesion. Our data using HEK293 cells show that while cell adhesion to collagen I was completely inhibited by anti-integrin blocking antibodies, the DDRs could mediate cell attachment to the GVMGFO motif in an integrin-independent manner. Cell binding to GVMGFO was independent of DDR receptor signalling and occurred with limited cell spreading, indicating that the DDRs do not mediate firm adhesion. However, blocking the interaction of DDR-expressing cells with collagen I via the GVMGFO site diminished cell adhesion, suggesting that the DDRs positively modulate integrin-mediated cell adhesion. Indeed, overexpression of the DDRs or activation of the DDRs by the GVMGFO ligand promoted α1β1 and α2β1 integrin-mediated cell adhesion to medium- and low-affinity integrin ligands without regulating the cell surface expression levels of α1β1 or α2β1. Our data thus demonstrate an adhesion-promoting role of the DDRs, whereby overexpression and/or activation of the DDRs leads to enhanced integrin-mediated cell adhesion as a result of higher integrin activation state.
References
[1]
Shoulders MD, Raines RT (2009) Collagen structure and stability. Annu Rev Biochem 78: 929–958.
[2]
Leitinger B (2011) Transmembrane collagen receptors. Annu Rev Cell Dev Biol 27: 265–290.
Popova SN, Lundgren-Akerlund E, Wiig H, Gullberg D (2007) Physiology and pathology of collagen receptors. Acta Physiol (Oxf) 190: 179–187.
[5]
Barczyk M, Carracedo S, Gullberg D (2010) Integrins. Cell Tissue Res 339: 269–280.
[6]
Farndale RW, Lisman T, Bihan D, Hamaia S, Smerling CS, et al. (2008) Cell-collagen interactions: the use of peptide Toolkits to investigate collagen-receptor interactions. Biochem Soc Trans 36: 241–250.
[7]
Knight CG, Morton LF, Onley DJ, Peachey AR, Messent AJ, et al. (1998) Identification in collagen type I of an integrin a2 b1-binding site containing an essential GER sequence. J Biol Chem 273: 33287–33294.
[8]
Knight CG, Morton LF, Peachey AR, Tuckwell DS, Farndale RW, et al. (2000) The Collagen-binding A-domains of Integrins a1b1 and a2b1 Recognize the Same Specific Amino Acid Sequence, GFOGER, in Native (Triple-helical) Collagens. J Biol Chem 275: 35–40.
[9]
Xu Y, Gurusiddappa S, Rich RL, Owens RT, Keene DR, et al. (2000) Multiple binding sites in collagen type I for the integrins a1b1 and a2b1. J Biol Chem 275: 38981–38989.
[10]
Raynal N, Hamaia SW, Siljander PR, Maddox B, Peachey AR, et al. (2006) Use of synthetic peptides to locate novel integrin alpha2beta1-binding motifs in human collagen III. J Biol Chem 281: 3821–3831.
[11]
Siljander PR, Hamaia S, Peachey AR, Slatter DA, Smethurst PA, et al. (2004) Integrin activation state determines selectivity for novel recognition sites in fibrillar collagens. J Biol Chem 279: 47763–47772.
[12]
Hamaia SW, Pugh N, Raynal N, Nemoz B, Stone R, et al. (2012) Mapping of Potent and Specific Binding Motifs, GLOGEN and GVOGEA, for Integrin alpha1beta1 Using Collagen Toolkits II and III. J Biol Chem 287: 26019–26028.
[13]
Ichikawa O, Osawa M, Nishida N, Goshima N, Nomura N, et al. (2007) Structural basis of the collagen-binding mode of discoidin domain receptor 2. Embo J 26: 4168–4176.
[14]
Carafoli F, Bihan D, Stathopoulos S, Konitsiotis AD, Kvansakul M, et al. (2009) Crystallographic insight into collagen recognition by discoidin domain receptor 2. Structure 17: 1573–1581.
[15]
Carafoli F, Mayer MC, Shiraishi K, Pecheva MA, Chan LY, et al. (2012) Structure of the discoidin domain receptor 1 extracellular region bound to an inhibitory Fab fragment reveals features important for signaling. Structure 20: 688–697.
[16]
Vogel W, Gish GD, Alves F, Pawson T (1997) The discoidin domain receptor tyrosine kinases are activated by collagen. Mol Cell 1: 13–23.
[17]
Shrivastava A, Radziejewski C, Campbell E, Kovac L, McGlynn M, et al. (1997) An orphan receptor tyrosine kinase family whose members serve as nonintegrin collagen receptors. Mol Cell 1: 25–34.
[18]
Leitinger B, Kwan AP (2006) The discoidin domain receptor DDR2 is a receptor for type X collagen. Matrix Biol 25: 355–364.
[19]
Leitinger B, Steplewski A, Fertala A (2004) The D2 period of collagen II contains a specific binding site for the human discoidin domain receptor, DDR2. J Mol Biol 344: 993–1003.
[20]
Noordeen NA, Carafoli F, Hohenester E, Horton MA, Leitinger B (2006) A transmembrane leucine zipper is required for activation of the dimeric receptor tyrosine kinase DDR1. J Biol Chem 281: 22744–22751.
[21]
Mihai C, Chotani M, Elton TS, Agarwal G (2009) Mapping of DDR1 distribution and oligomerization on the cell surface by FRET microscopy. J Mol Biol 385: 432–445.
[22]
Konitsiotis AD, Raynal N, Bihan D, Hohenester E, Farndale RW, et al. (2008) Characterization of high affinity binding motifs for the discoidin domain receptor DDR2 in collagen. J Biol Chem 283: 6861–6868.
[23]
Xu H, Raynal N, Stathopoulos S, Myllyharju J, Farndale RW, et al. (2011) Collagen binding specificity of the discoidin domain receptors: binding sites on collagens II and III and molecular determinants for collagen IV recognition by DDR1. Matrix Biol 30: 16–26.
[24]
Emsley J, King SL, Bergelson JM, Liddington RC (1997) Crystal structure of the I domain from integrin a2b1. J Biol Chem 272: 28512–28517.
[25]
Vogel WF, Aszodi A, Alves F, Pawson T (2001) Discoidin domain receptor 1 tyrosine kinase has an essential role in mammary gland development. Mol Cell Biol 21: 2906–2917.
[26]
Labrador JP, Azcoitia V, Tuckermann J, Lin C, Olaso E, et al. (2001) The collagen receptor DDR2 regulates proliferation and its elimination leads to dwarfism. EMBO Rep 2: 446–452.
[27]
Bargal R, Cormier-Daire V, Ben-Neriah Z, Le Merrer M, Sosna J, et al. (2009) Mutations in DDR2 gene cause SMED with short limbs and abnormal calcifications. Am J Hum Genet 84: 80–84.
[28]
Ali BR, Xu H, Akawi NA, John A, Karuvantevida NS, et al. (2010) Trafficking defects and loss of ligand binding are the underlying causes of all reported DDR2 missense mutations found in SMED-SL patients. Hum Mol Genet 19: 2239–2250.
[29]
Vogel WF, Abdulhussein R, Ford CE (2006) Sensing extracellular matrix: An update on discoidin domain receptor function. Cell Signal 18: 1108–1116.
[30]
Valiathan RR, Marco M, Leitinger B, Kleer CG, Fridman R (2012) Discoidin domain receptor tyrosine kinases: new players in cancer progression. Cancer Metastasis Rev 31: 295–321.
[31]
Kamohara H, Yamashiro S, Galligan C, Yoshimura T (2001) Discoidin domain receptor 1 isoform-a (DDR1a) promotes migration of leukocytes in three-dimensional collagen lattices. Faseb J 15: 2724–2726.
[32]
Yoshida D, Teramoto A (2007) Enhancement of pituitary adenoma cell invasion and adhesion is mediated by discoidin domain receptor-1. J Neurooncol 82: 29–40.
[33]
Ram R, Lorente G, Nikolich K, Urfer R, Foehr E, et al. (2006) Discoidin Domain Receptor-1a (DDR1a) Promotes Glioma Cell Invasion and Adhesion in Association with Matrix Metalloproteinase-2. J Neurooncol 76: 239–248.
Curat CA, Vogel WF (2002) Discoidin domain receptor 1 controls growth and adhesion of mesangial cells. J Am Soc Nephrol 13: 2648–2656.
[36]
Wang CZ, Su HW, Hsu YC, Shen MR, Tang MJ (2006) A Discoidin Domain Receptor 1/SHP-2 Signaling Complex Inhibits {alpha}2beta1-Integrin-mediated Signal Transducers and Activators of Transcription 1/3 Activation and Cell Migration. Mol Biol Cell 17: 2839–2852.
[37]
Yeh YC, Wang CZ, Tang MJ (2009) Discoidin domain receptor 1 activation suppresses alpha2beta1 integrin-dependent cell spreading through inhibition of Cdc42 activity. J Cell Physiol 218: 146–156.
[38]
Huang Y, Arora P, McCulloch CA, Vogel WF (2009) The collagen receptor DDR1 regulates cell spreading and motility by associating with myosin IIA. J Cell Sci 122: 1637–1646.
[39]
Vogel W, Brakebusch C, Fassler R, Alves F, Ruggiero F, et al. (2000) Discoidin domain receptor 1 is activated independently of β1 integrin. J Biol Chem 275: 5779–5784.
[40]
Shintani Y, Fukumoto Y, Chaika N, Svoboda R, Wheelock MJ, et al. (2008) Collagen I-mediated up-regulation of N-cadherin requires cooperative signals from integrins and discoidin domain receptor 1. J Cell Biol 180: 1277–1289.
[41]
Suh HN, Han HJ (2011) Collagen I regulates the self-renewal of mouse embryonic stem cells through alpha2beta1 integrin- and DDR1-dependent Bmi-1. J Cell Physiol 226: 3422–3432.
[42]
Leitinger B (2003) Molecular analysis of collagen binding by the human discoidin domain receptors, DDR1 and DDR2. Identification of collagen binding sites in DDR2. J Biol Chem 278: 16761–16769.
[43]
Taherian A, Li X, Liu Y, Haas TA (2011) Differences in integrin expression and signaling within human breast cancer cells. BMC Cancer 11: 293.
[44]
Nam S, Kim D, Cheng JQ, Zhang S, Lee JH, et al. (2005) Action of the Src family kinase inhibitor, dasatinib (BMS-354825), on human prostate cancer cells. Cancer Res 65: 9185–9189.
[45]
Rix U, Hantschel O, Durnberger G, Remsing Rix LL, Planyavsky M, et al. (2007) Chemical proteomic profiles of the BCR-ABL inhibitors imatinib, nilotinib, and dasatinib reveal novel kinase and nonkinase targets. Blood 110: 4055–4063.
[46]
Day E, Waters B, Spiegel K, Alnadaf T, Manley PW, et al. (2008) Inhibition of collagen-induced discoidin domain receptor 1 and 2 activation by imatinib, nilotinib and dasatinib. Eur J Pharmacol 599: 44–53.
[47]
Hou G, Vogel WF, Bendeck MP (2002) Tyrosine kinase activity of discoidin domain receptor 1 is necessary for smooth muscle cell migration and matrix metalloproteinase expression. Circ Res 90: 1147–1149.
[48]
Morton LF, Peachey AR, Barnes MJ (1989) Platelet-reactive sites in collagens type I and type III. Evidence for separate adhesion and aggregatory sites. Biochem J 258: 157–163.
[49]
Santoro SA, Walsh JJ, Staatz WD, Baranski KJ (1991) Distinct determinants on collagen support alpha 2 beta 1 integrin-mediated platelet adhesion and platelet activation. Cell Regul 2: 905–913.
[50]
Nieuwenhuis HK, Akkerman JW, Houdijk WP, Sixma JJ (1985) Human blood platelets showing no response to collagen fail to express surface glycoprotein Ia. Nature 318: 470–472.
[51]
Moroi M, Jung SM, Okuma M, Shinmyozu K (1989) A patient with platelets deficient in glycoprotein VI that lack both collagen-induced aggregation and adhesion. J Clin Invest 84: 1440–1445.
[52]
Chen J, Diacovo TG, Grenache DG, Santoro SA, Zutter MM (2002) The α2 integrin subunit-deficient mouse: a multifaceted phenotype including defects of branching morphogenesis and hemostasis. Am J Pathol 161: 337–344.
[53]
Kato K, Kanaji T, Russell S, Kunicki TJ, Furihata K, et al. (2003) The contribution of glycoprotein VI to stable platelet adhesion and thrombus formation illustrated by targeted gene deletion. Blood 102: 1701–1707.
[54]
Munnix IC, Gilio K, Siljander PR, Raynal N, Feijge MA, et al. (2008) Collagen-mimetic peptides mediate flow-dependent thrombus formation by high- or low-affinity binding of integrin alpha2beta1 and glycoprotein VI. J Thromb Haemost 6: 2132–2142.
[55]
Pugh N, Simpson AM, Smethurst PA, de Groot PG, Raynal N, et al. (2010) Synergism between platelet collagen receptors defined using receptor-specific collagen-mimetic peptide substrata in flowing blood. Blood 115: 5069–5079.
[56]
Sabri S, Jandrot-Perrus M, Bertoglio J, Farndale RW, Mas VM, et al. (2004) Differential regulation of actin stress fiber assembly and proplatelet formation by alpha2beta1 integrin and GPVI in human megakaryocytes. Blood 104: 3117–3125.
[57]
Reyes CD, Garcia AJ (2003) Engineering integrin-specific surfaces with a triple-helical collagen-mimetic peptide. J Biomed Mater Res A 65: 511–523.
[58]
Khew ST, Zhu XH, Tong YW (2007) An integrin-specific collagen-mimetic peptide approach for optimizing Hep3B liver cell adhesion, proliferation, and cellular functions. Tissue Eng 13: 2451–2463.
Luo BH, Carman CV, Springer TA (2007) Structural basis of integrin regulation and signaling. Annu Rev Immunol 25: 619–647.
[61]
Nilsson S, Kaniowska D, Brakebusch C, Fassler R, Johansson S (2006) Threonine 788 in integrin subunit beta1 regulates integrin activation. Exp Cell Res 312: 844–853.
[62]
Honda S, Shirotani-Ikejima H, Tadokoro S, Maeda Y, Kinoshita T, et al. (2009) Integrin-linked kinase associated with integrin activation. Blood 113: 5304–5313.
[63]
Byron A, Humphries JD, Askari JA, Craig SE, Mould AP, et al. (2009) Anti-integrin monoclonal antibodies. J Cell Sci 122: 4009–4011.
[64]
Bazzoni G, Ma L, Blue M-L, Hemler ME (1998) Divalent cations and ligands induce conformational changes that are highly divergent among β1 integrins. J Biol Chem 273: 6670–6678.
[65]
Franco C, Britto K, Wong E, Hou G, Zhu SN, et al. (2009) Discoidin domain receptor 1 on bone marrow-derived cells promotes macrophage accumulation during atherogenesis. Circ Res 105: 1141–1148.
[66]
Fukunaga-Kalabis M, Martinez G, Liu ZJ, Kalabis J, Mrass P, et al. (2006) CCN3 controls 3D spatial localization of melanocytes in the human skin through DDR1. J Cell Biol 175: 563–569.
[67]
Hidalgo-Carcedo C, Hooper S, Chaudhry SI, Williamson P, Harrington K, et al. (2011) Collective cell migration requires suppression of actomyosin at cell-cell contacts mediated by DDR1 and the cell polarity regulators Par3 and Par6. Nat Cell Biol 13: 49–58.
[68]
Valencia K, Ormazabal C, Zandueta C, Luis-Ravelo D, Anton I, et al. (2012) Inhibition of collagen receptor discoidin domain receptor-1 (DDR1) reduces cell survival, homing, and colonization in lung cancer bone metastasis. Clin Cancer Res 18: 969–980.
[69]
Chetoui N, El Azreq MA, Boisvert M, Bergeron ME, Aoudjit F (2011) Discoidin domain receptor 1 expression in activated T cells is regulated by the ERK MAP kinase signaling pathway. J Cell Biochem 112: 3666–3674.
[70]
Hou G, Wang D, Bendeck MP (2012) Deletion of discoidin domain receptor 2 does not affect smooth muscle cell adhesion, migration, or proliferation in response to type I collagen. Cardiovasc Pathol 21: 214–218.
[71]
Olaso E, Labrador JP, Wang L, Ikeda K, Eng FJ, et al. (2002) Discoidin domain receptor 2 regulates fibroblast proliferation and migration through the extracellular matrix in association with transcriptional activation of matrix metalloproteinase-2. J Biol Chem 277: 3606–3613.
[72]
Vonk LA, Doulabi BZ, Huang C, Helder MN, Everts V, et al. (2011) Collagen-induced expression of collagenase-3 by primary chondrocytes is mediated by integrin α1 and discoidin domain receptor 2: a protein kinase C-dependent pathway. Rheumatology 50: 463–472.
